28 April,2021 06:09 PM IST | Pune | mid-day online correspondent
File Pic
Serum Institute of India's CEO, Adar Poonawalla, on Wednesday, announced that Covishield's price for states will be slashed from Rs 400 to Rs 300 as a philanthropic gesture.
Taking to Twitter, Poonawalla said, "As a philanthropic gesture on behalf of @SerumInstIndia, I hereby reduce the price to the states from Rs.400 to Rs.300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives."
ALSO READ
Bharat Biotech launches oral vaccine against cholera, targets 200 million doses
As WHO declares mpox outbreak an emergency, watch out for these symptoms
Bharat Biotech co-founder Dr. Krishna Ella awarded by Johns Hopkins
India records 441 fresh COVID-19 JN.1 variant cases, active cases has gone down
Delhi's Safdarjung hospital gears up to treat COVID-19 patients
Covishield's price for private hospitals remains at Rs 600 per dose.
This follows widespread criticism of its pricing policy as it had sold the initial doses of Covishield to the central government at Rs 150 per dose.
Both Bharat Biotech and Serum's vaccines are available to the central government at a rate of Rs 150 per dose.
